Clinical Trial Update: Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effect of adding dapagliflozin to metformin on body weight in adults with type 2 diabetes mellitus; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2013-10-14